Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H16ClF6N5O |
Molecular Weight | 587.903 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C1=CC(=CC(CN2N=NC(=C2C3=CC=NC=C3)C4=NC=CC=C4C(=O)C5=C(Cl)C=CC=C5)=C1)C(F)(F)F
InChI
InChIKey=CAVRKWRKTNINFF-UHFFFAOYSA-N
InChI=1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2
Molecular Formula | C28H16ClF6N5O |
Molecular Weight | 587.903 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tradipitant is a neurokinin 1 receptor antagonist. The dose of 50 mg of tradipitant given orally for 4 weeks was not superior to placebo in reducing itch intensity in patients with atopic dermatitis. However, in a subsequent study, in which a higher dose (85 mg) was administered for 8 weeks, significant antipruritic effect compared with placebo was recorded. Tradipitant is in phase III clinical trial for the treatment of atopic dermatitis and gastroparesis. Vanda Pharmaceuticals plans a phase III trial in Motion Sickness in 2019.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL249 Sources: https://www.ncbi.nlm.nih.gov/pubmed/31190215 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:47:31 GMT 2023
by
admin
on
Fri Dec 15 16:47:31 GMT 2023
|
Record UNII |
NY0COC51FI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78284
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000021772
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
NY0COC51FI
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
CD-17
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
DTXSID801045805
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
Tradipitant
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
DB12580
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
9916461
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544984
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
C152707
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
9996
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY | |||
|
622370-35-8
Created by
admin on Fri Dec 15 16:47:31 GMT 2023 , Edited by admin on Fri Dec 15 16:47:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |